Study tracks 400 patients to see how standard treatment for prescription drug addiction works
NCT ID NCT03713983
First seen Jun 26, 2026 · Last updated Jun 26, 2026
Summary
This study follows 400 adults receiving standard treatment for prescription narcotic drug use disorder, including opioids and benzodiazepines. Researchers will measure how many patients reduce or stop using these drugs and what factors help. No new treatments are tested; the goal is to gather information for future studies.
What this could mean
Our plain-language read of the trial. This is informational only — not medical advice or a prediction.
- What this could lead to
- If successful, this study could provide insights to design better treatments for prescription narcotic drug use disorder.
- What could go wrong
- This is an observational study, not testing a new treatment. Results may not lead to immediate changes in care.
This is an AI summary of the original study and may miss details. Read our disclaimer.
Get updates
Get notified about this study
Sign up to get updates when this study changes or when new studies for DRUG USE DISORDERS are added.
By submitting, you agree to our Terms of use
Conditions
The condition(s) this trial relates to.
As listed by the trial registrant
The condition terms exactly as the trial's registrant entered them.
Contacts and locations
Locations
-
Stockholm Centre for Dependency Disorders (www.beroendecentrum.se)
Stockholm, Sweden
More trials for these conditions
Other studies related to the condition(s) this trial covers.
- Can a single chat with a partner keep people who inject drugs in care?
- Can smartphone apps help fight addiction in primary care? large study tests new approach.
- New behavioral program aims to curb HIV and drug use in High-Risk men
- Personal navigators may boost substance use treatment success
- Navigating barriers: new pilot aims to boost substance use treatment access